Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Phase 1 Study in Healthy Participants to Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations

NCT04969965 is registered in ClinicalTrials.gov with EQRx, Inc. as lead sponsor.

NCT NCT04969965
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04969965 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Phase 1 Study in Healthy Participants to Evaluate the Comparative Pharmacokinetics of Orally Administered EQ143 in Different Racial and Ethnic Populations
Lead sponsor
EQRx, Inc.
Phase
Phase 1
Overall status
Completed
Start date
June 21, 2021
Completion date
October 7, 2021
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, nsclc, pharmacokinetics